Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2009 Feb;33(2):309-12.
doi: 10.1097/PAS.0b013e3181882c3d.

Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome

Affiliations
Case Reports

Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome

Jennifer A Sparr et al. Am J Surg Pathol. 2009 Feb.

Abstract

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is a precancerous lesion with a well-described progression to carcinoma. This case report describes a 61-year-old woman with a history significant for multiple cancers and a confirmed germline mutation of MSH2, a mismatch repair gene responsible for Lynch syndrome, who was also found to have an IPMN of the pancreas. Phenotypic manifestations of Lynch syndrome in this patient included multiple adenomas and adenocarcinomas of the colon and also several other Lynch syndrome-associated cancers. The patient's adenocarcinoma of the colon and IPMN of the pancreas showed identical immunohistochemical staining profiles with loss of expression of MSH2 and MSH6 proteins and high levels of microsatellite instability. The immunohistochemical staining and microsatellite instability patterns of the adenocarcinoma of the colon and IPMN gives strong evidence to support the consideration of IPMN as part of the spectrum of lesions found in Lynch syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Microphotographs of the IPMN A) Low-Power H&E staining B) High-power H&E staining C) Intact MLH1 immunohistochemical staining, D) Absence of MSH2 immunohistochemical staining
Figure 1
Figure 1
Microphotographs of the IPMN A) Low-Power H&E staining B) High-power H&E staining C) Intact MLH1 immunohistochemical staining, D) Absence of MSH2 immunohistochemical staining
Figure 1
Figure 1
Microphotographs of the IPMN A) Low-Power H&E staining B) High-power H&E staining C) Intact MLH1 immunohistochemical staining, D) Absence of MSH2 immunohistochemical staining
Figure 1
Figure 1
Microphotographs of the IPMN A) Low-Power H&E staining B) High-power H&E staining C) Intact MLH1 immunohistochemical staining, D) Absence of MSH2 immunohistochemical staining

References

    1. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999;81:214–218. - PubMed
    1. Banville N, Geraghty R, Fox E, et al. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol. 2006;37:1498–1502. - PubMed
    1. Chetty R, Salahshor S, Bapat B, et al. Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J Clin Pathol. 2005;58:97–101. - PMC - PubMed
    1. Choi MG, Kim SW, Han SS, et al. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg. 2006;141:51–56. discussion 56. - PubMed
    1. Goggins M, Offerhaus GJ, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ Am J Pathol. 1998;152:1501–1507. - PMC - PubMed

Publication types

MeSH terms